Pharma
PanGraf 0.5 Tacrolimus Capsules 0.5 mg
Immunosuppressant agent; 0.5 mg Tacrolimus capsules for organ transplant rejection prophylaxis.
PanGraf 0.5 Tacrolimus Capsules 0.5 mg
PanGraf 0.5 contains 0.5 mg of Tacrolimus, a potent immunosuppressant (calcineurin inhibitor). It is primarily indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver, kidney, or heart transplants. It works by inhibiting T-lymphocyte activation. Due to its narrow therapeutic index, blood level monitoring is often required. Common side effects may include tremors, headache, kidney function changes, and increased risk of infections. Use strictly under specialist supervision.
You May Also Like
Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.